CareCloud Résultats passés
Passé contrôle des critères 3/6
CareCloud a connu une croissance annuelle moyenne de ses bénéfices de 6.8%, tandis que le secteur Healthcare Services a vu ses bénéfices augmenter de en hausse à 20.5% par an. Les revenus ont augmenté de en baisse à un taux moyen de 4% par an. Le rendement des capitaux propres de CareCloud est 16.8% et ses marges nettes sont de 3.5%.
Informations clés
6.85%
Taux de croissance des bénéfices
8.20%
Taux de croissance du BPA
| Healthcare Services Croissance de l'industrie | 1.72% |
| Taux de croissance des recettes | -3.96% |
| Rendement des fonds propres | 16.75% |
| Marge nette | 3.47% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • May 13
CCLD: Clearer Organic Revenue Trends Will Support Future Upside Potential
Analysts have trimmed their average price target on CareCloud to $3.25, citing concerns that recent acquisitions, including a planned aircraft purchase, are masking underlying revenue declines and adding nonessential spending to the story. Analyst Commentary Bullish analysts are weighing CareCloud's recent moves against concerns around revenue trends and spending, and are looking closely at how management deploys capital from acquisitions and new initiatives.Article d’analyse • May 11
The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...
Mise à jour du récit • Apr 29
CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence
Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.
Mise à jour du récit • Apr 14
CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending
Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.Mise à jour du récit • Mar 31
CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential
Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.Mise à jour du récit • Mar 17
CCLD: Higher Margins And New Contracts Will Support Future Upside
Analysts have trimmed CareCloud's price target to $3.25. This reflects concerns that acquisitive activity, including the planned aircraft purchase, is obscuring underlying revenue softness, even as profit margin assumptions improve and future P/E expectations reset lower.Mise à jour du récit • Mar 02
CCLD: Supply Chain And Urgent Care Expansion Will Support Future Upside
Analysts have adjusted their CareCloud price target to reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. This has led to a revised view of the potential upside for the shares.Mise à jour du récit • Feb 16
CCLD: Cost Controls And AI Automation Will Drive Future Repricing Potential
Analysts have updated their view on CareCloud with a revised $3.25 price target, citing refreshed assumptions for revenue growth, profit margins, discount rate and future P/E, while also pointing to recent Street research, including new coverage with an $8 target, as context for the valuation range. Analyst Commentary The refreshed $3.25 target sits well below the new $8 initiation level referenced in Street research, which highlights how split opinions are around CareCloud’s execution and valuation.Article d’analyse • Feb 04
Take Care Before Diving Into The Deep End On CareCloud, Inc. (NASDAQ:CCLD)
You may think that with a price-to-sales (or "P/S") ratio of 0.9x CareCloud, Inc. ( NASDAQ:CCLD ) is a stock worth...Mise à jour du récit • Feb 02
CCLD: Cost Discipline And AI Rollout Will Support Future Rerating Potential
Analysts have nudged their price target for CareCloud higher, with some recent research pointing to a range up to US$8. This reflects revised assumptions for cost controls, a flatter near term revenue and EBITDA outlook, and a higher future P/E multiple in their models.Seeking Alpha • Jan 29
CareCloud: Undervalued AI Play In Healthcare IT
Summary CareCloud is transitioning from an RCM provider to AI-driven healthcare IT, targeting higher-margin recurring revenues. I assign CCLD a buy rating with a 1-year price target of $4.3, implying 48% upside from $2.9. Recent performance shows six consecutive quarters of GAAP profitability, strong cost control, and solid operating cash flow. Key risks include 2026 state AI regulations, which may limit adoption of CCLD’s new AI voice solutions. Read the full article on Seeking AlphaMise à jour du récit • Jan 19
CCLD: Cost Controls And AI Automation Will Support Future Repricing
Analysts have adjusted their price target on CareCloud to $3.25 based on updated views of revenue growth, profit margins, cost controls, and long-term P/E assumptions following recent research, including new coverage with an $8 target and revised estimates after the latest Q3 report. Analyst Commentary Recent research on CareCloud reflects a mix of optimism and restraint, with one firm starting coverage at a higher price target and others resetting expectations closer to current fundamentals.Mise à jour du récit • Jan 05
CCLD: Cost Controls And New AI Offering Will Support Future Upside
Narrative Update on CareCloud Analysts have lifted their price target on CareCloud to $3.25 from $2.25, citing updated forecasts for revenue growth, a different margin profile, a higher assumed future P/E multiple, and recent Street research that includes new coverage and refreshed estimates following the Q3 report. Analyst Commentary Recent Street research on CareCloud offers a mixed picture, with some upbeat coverage alongside more cautious views.Mise à jour du récit • Dec 15
CCLD: Cost Controls And EBITDA Durability Will Drive Shares Higher
Analysts have raised their price target on CareCloud to $8.00 from prior levels near $3.25, citing new Buy-rated coverage and expectations that tighter cost controls will support near term EBITDA even as revenue growth moderates. Analyst Commentary Bullish analysts point to recent price target increases as evidence that the market may be underestimating CareCloud's ability to sustain profitability while navigating slower top line growth.Mise à jour du récit • Dec 01
CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum
CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.Mise à jour du récit • Nov 17
CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability
CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.Article d’analyse • Aug 26
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 30% Share Price Rise
Despite an already strong run, CareCloud, Inc. ( NASDAQ:CCLD ) shares have been powering on, with a gain of 30% in the...Article d’analyse • May 01
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 33% Share Price Rise
Those holding CareCloud, Inc. ( NASDAQ:CCLD ) shares would be relieved that the share price has rebounded 33% in the...
Nouveau récit • Apr 12
CirrusAI, Series Conversion And Acquisition Reentry Will Unlock New Opportunities
AI-driven solutions and innovations, including CirrusAI, position CareCloud for enhanced revenue growth and new market opportunities.Article d’analyse • Mar 16
Analysts Have Been Trimming Their CareCloud, Inc. (NASDAQ:CCLD) Price Target After Its Latest Report
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its annual...Article d’analyse • Mar 13
Not Many Are Piling Into CareCloud, Inc. (NASDAQ:CCLD) Stock Yet As It Plummets 65%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders won't be pleased to see that the share price has had a very rough month...Article d’analyse • Feb 19
CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Article d’analyse • Jan 18
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...Article d’analyse • Nov 13
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders have had their patience rewarded with a 34% share price jump in the last...Article d’analyse • Oct 07
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d’analyse • Aug 31
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Article d’analyse • Jul 13
CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...Article d’analyse • Jun 27
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d’analyse • May 22
CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders would be excited to see that the share price has had a great month...Article d’analyse • Mar 22
CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate
Key Insights CareCloud's estimated fair value is US$1.92 based on 2 Stage Free Cash Flow to Equity CareCloud is...Article d’analyse • Mar 22
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Article d’analyse • Feb 02
Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding
The CareCloud, Inc. ( NASDAQ:CCLD ) share price has softened a substantial 25% over the previous 30 days, handing back...Article d’analyse • Jan 30
Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d’analyse • Dec 19
CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Article d’analyse • Sep 28
Is CareCloud (NASDAQ:CCLD) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Aug 05
Things Look Grim For CareCloud, Inc. (NASDAQ:CCLD) After Today's Downgrade
Today is shaping up negative for CareCloud, Inc. ( NASDAQ:CCLD ) shareholders, with the analysts delivering a...Article d’analyse • Aug 01
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues
With a price-to-sales (or "P/S") ratio of 0.4x CareCloud, Inc. ( NASDAQ:CCLD ) may be sending very bullish signals at...Article d’analyse • May 06
CareCloud, Inc. (NASDAQ:CCLD) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Last week, you might have seen that CareCloud, Inc. ( NASDAQ:CCLD ) released its first-quarter result to the market...Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment CareCloud gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 124 | 4 | 25 | 8 |
| 31 Dec 25 | 120 | 4 | 23 | 6 |
| 30 Sep 25 | 114 | 2 | 22 | 5 |
| 30 Jun 25 | 112 | 0 | 22 | 4 |
| 31 Mar 25 | 113 | -4 | 22 | 4 |
| 31 Dec 24 | 111 | -4 | 22 | 4 |
| 30 Sep 24 | 111 | -52 | 24 | 4 |
| 30 Jun 24 | 112 | -58 | 26 | 4 |
| 31 Mar 24 | 113 | -62 | 29 | 5 |
| 31 Dec 23 | 117 | -64 | 31 | 5 |
| 30 Sep 23 | 121 | -20 | 32 | 5 |
| 30 Jun 23 | 126 | -16 | 33 | 5 |
| 31 Mar 23 | 133 | -12 | 33 | 4 |
| 31 Dec 22 | 139 | -10 | 34 | 4 |
| 30 Sep 22 | 144 | -7 | 34 | 3 |
| 30 Jun 22 | 148 | -6 | 34 | 3 |
| 31 Mar 22 | 145 | -9 | 33 | 3 |
| 31 Dec 21 | 140 | -11 | 33 | 4 |
| 30 Sep 21 | 134 | -15 | 31 | 7 |
| 30 Jun 21 | 128 | -18 | 31 | 9 |
| 31 Mar 21 | 113 | -23 | 29 | 9 |
| 31 Dec 20 | 105 | -23 | 29 | 9 |
| 30 Sep 20 | 89 | -21 | 26 | 7 |
| 30 Jun 20 | 74 | -16 | 23 | 5 |
| 31 Mar 20 | 71 | -11 | 22 | 3 |
| 31 Dec 19 | 64 | -7 | 19 | 1 |
| 30 Sep 19 | 65 | -8 | 21 | 1 |
| 30 Jun 19 | 65 | -9 | 21 | 1 |
| 31 Mar 19 | 57 | -8 | 19 | 1 |
| 31 Dec 18 | 51 | -7 | 18 | 1 |
| 30 Sep 18 | 42 | -6 | 16 | 1 |
| 30 Jun 18 | 33 | -4 | 13 | 1 |
| 31 Mar 18 | 32 | -5 | 12 | 1 |
| 31 Dec 17 | 32 | -8 | 13 | 1 |
| 30 Sep 17 | 32 | -11 | 13 | 1 |
| 30 Jun 17 | 30 | -11 | 13 | 1 |
| 31 Mar 17 | 28 | -10 | 13 | 1 |
| 31 Dec 16 | 24 | -10 | 13 | 1 |
| 30 Sep 16 | 21 | -6 | 12 | 1 |
| 30 Jun 16 | 21 | -6 | 12 | 1 |
| 31 Mar 16 | 22 | -6 | 12 | 1 |
| 31 Dec 15 | 23 | -5 | 12 | 1 |
| 30 Sep 15 | 25 | -5 | 13 | 1 |
| 30 Jun 15 | 25 | -6 | 13 | 1 |
Des revenus de qualité: CCLD a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: CCLD est devenu rentable dans le passé.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: CCLD est devenue rentable au cours des 5 dernières années, augmentant ses bénéfices de 6.8% par an.
Accélération de la croissance: CCLD est devenu rentable au cours de l'année dernière, ce qui rend le taux de croissance des bénéfices difficile à comparer à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: CCLD est devenue rentable au cours de l'année dernière, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Healthcare Services ( 4.2% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de CCLD ( 16.8% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/21 07:40 |
| Cours de l'action en fin de journée | 2026/05/21 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
CareCloud, Inc. est couverte par 8 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Keay Nakae | Chardan Capital Markets, LLC |
| Eugene Mannheimer | Colliers Securities |